Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  La Jolla Pharmaceutical Company    LJPCD

SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

LA JOLLA PHARMACEUTICAL COMPANY : REVERSE SPLIT: 1 of 50

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/14/2014 CET
A split is applied today to La Jolla Pharmaceutical Company's stock price.


© Factset 2014
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LA JOLLA PHARMACEUTICAL CO
03:30p LA JOLLA PHARMACEUTICAL COMPANY : Dow Continues Record Streak: Today's Research ..
02:18p LA JOLLA PHARMACEUTICAL COMPANY : Blog Coverage La Jolla's Lead Product Candidat..
02/27 LA JOLLA PHARMACEUTICAL COMPANY : Announces Positive Top-Line Results from ATHOS..
02/24 LA JOLLA PHARMACEUTICAL : posts 4Q loss
02/23 LA JOLLA PHARMACEUTICAL COMPANY (NAS : LJPC) Files An 8-K Results of Operations ..
02/23 LA JOLLA PHARMACEUTICAL CO : Results of Operations and Financial Condition, Fina..
02/23 LA JOLLA PHARMACEUTICAL COMPANY : Announces Fourth Quarter and Full Year 2016 Fi..
02/23 LA JOLLA PHARMACEUTICAL : Management's Discussion and Analysis of Financial Cond..
01/23 LA JOLLA PHARMACEUTICAL COMPANY : LifeSci Capital Initiates Coverage of La Jolla..
01/21 LA JOLLA PHARMACEUTICAL : Sepsis Alliance Announces National Partnership with La..
More news
Sector news : Bio Therapeutic Drugs
02/27DJSANOFI : Lonza to Invest CHF290 Million in New Plant in Switzerland
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
More sector news : Bio Therapeutic Drugs
Advertisement
Financials ($)
Sales 2017 0,49 M
EBIT 2017 -102 M
Net income 2017 -99,7 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 1 317x
Capi. / Sales 2018 13,5x
Capitalization 641 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 53,8 $
Spread / Average Target 53%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
George Francis Tidmarsh President, CEO, Secretary & Director
Kevin C. Tang Chairman
Jennifer Carver Senior Vice President-Operations
Dennis M. Mulroy Chief Financial & Accounting Officer
Lakhmir S. Chawla Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LA JOLLA PHARMACEUTICA..0.00%641
AMGEN, INC.19.39%129 711
CELGENE CORPORATION2.14%94 741
GILEAD SCIENCES, INC.-2.33%92 881
REGENERON PHARMACEUTIC..-1.66%39 573
ACTELION LTD22.36%28 883
More Results